Sign in
4

Changes in Ownership

REPLIGEN CORP Filed Acc 0000899243-22-028506

Senior VP, R&D sold 4,840 shares at an average $254.32 ($1,230,886)

  • Senior VP, R&D acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KURIYEL RALF Senior VP, R&D 2022-08-11 Option exercise +2,000 $33.05 $66,100 22,110 D
KURIYEL RALF Senior VP, R&D 2022-08-11 Option exercise +1,354 $59.52 $80,590 23,464 D
KURIYEL RALF Senior VP, R&D 2022-08-11 Option exercise +646 $86.10 $55,621 24,110 D
KURIYEL RALF Senior VP, R&D 2022-08-11 Sale −800 $255.20 $204,160 23,310 D
KURIYEL RALF Senior VP, R&D 2022-08-11 Sale −4,040 $254.14 $1,026,726 19,270 D
Derivatives
KURIYEL RALF Senior VP, R&D 2022-08-11 Option exercise · Stock Option (Right to Buy) +2,000 0 D
KURIYEL RALF Senior VP, R&D 2022-08-11 Option exercise · Stock Option (Right to Buy) +1,354 0 D
KURIYEL RALF Senior VP, R&D 2022-08-11 Option exercise · Stock Option (Right to Buy) +646 400 D
Open-market sales · 4,840 sh · avg $254.32 · $1,230,886
Loading xslF345X03/doc4.xml…